+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Nutraceuticals Market by Product Type, Form, Source, Application, End-User, Distribution Channel - Global Forecast to 2030

  • PDF Icon

    Report

  • 195 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 4829827
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Nutraceuticals Market grew from USD 541.89 billion in 2024 to USD 581.94 billion in 2025. It is expected to continue growing at a CAGR of 7.54%, reaching USD 838.25 billion by 2030.

Setting the Stage for Nutraceuticals Growth and Innovation

Nutraceuticals represent a dynamic convergence of nutrition and pharmaceuticals, offering preventive and therapeutic benefits beyond traditional food products. As global populations age and healthcare systems face cost pressures, the appeal of dietary supplements, functional beverages, and functional foods has never been stronger. This executive summary examines the forces propelling the sector, from heightened consumer health awareness to breakthroughs in ingredient science and delivery technologies.

Rising interest in proactive well-being, fueled by a growing body of research linking diet to chronic disease prevention, has spurred demand for vitamins, minerals, and botanical extracts. Simultaneously, innovations in microencapsulation and targeted delivery are unlocking new possibilities in functional beverages and fortified foods. Companies keen to capitalize on these trends must navigate a complex web of regulations, distribution channels, and competitive pressures.

This summary distills key transformative shifts reshaping the nutraceutical ecosystem, evaluates the cumulative impact of United States tariffs in 2025, highlights critical segmentation insights, and offers a regional perspective on market dynamics. We also spotlight leading players, propose actionable recommendations for industry leaders, and outline the rigorous methodology that underpins our conclusions. By synthesizing these elements, this overview equips decision-makers with the context and clarity needed to chart a confident path forward.

Emerging Forces Redefining the Nutraceutical Landscape

The nutraceutical landscape is undergoing profound transformation as consumer expectations evolve beyond mere product efficacy toward holistic brand experiences. Sustainability has emerged as a nonnegotiable attribute, with ingredient traceability and eco-friendly packaging becoming key differentiators in an increasingly crowded marketplace. In response, agile players are forging partnerships with growers and ingredient suppliers to secure ethically sourced botanicals and animal-free proteins.

Parallel to this, the rise of personalized nutrition is rewriting traditional one-size-fits-all formulas. Advances in gut microbiome profiling and digital health platforms are enabling bespoke formulations that address individual metabolic and genetic profiles. Companies that integrate data analytics and consumer engagement tools into their R&D pipelines will be best positioned to deliver tailored solutions that drive loyalty and premium pricing.

Moreover, the digitization of distribution channels has accelerated during the past two years, with e-commerce platforms and direct-to-consumer models gaining significant traction. Brands are investing in immersive online experiences, leveraging augmented reality and AI-driven recommendations to educate and convert health enthusiasts. At the same time, strategic alliances between conventional food manufacturers and specialty supplement firms are blurring category boundaries, unlocking new avenues for cross-category innovation.

Assessing the Cumulative Impact of U.S. Tariffs in 2025

In early 2025, the United States imposed incremental tariffs on a range of nutraceutical ingredients imported from select regions, aiming to bolster domestic manufacturing. While the policy incentivizes onshore production of key inputs, it also elevates cost structures for brands reliant on global supply chains. Manufacturers face higher raw material expenses, particularly for exotic botanicals and marine-derived compounds sourced from overseas.

These increased duties have led to strategic recalibration across the value chain. Several companies have expedited investments in domestic extraction facilities and research centers, seeking to localize production of amino acids, herbal extracts, and omega-3 concentrates. Concurrently, some import-dependent players are exploring tariff engineering tactics, breaking down shipments to qualify for lower duty classifications. However, these workarounds often introduce logistical complexity and compliance risk.

Price sensitivity among end-users remains a concern, particularly in mass-market segments. To preserve margins, leading brands are optimizing formulas by substituting high-cost ingredients with locally sourced alternatives, or by extending shelf-stable powder forms. Although these measures mitigate tariff impact, they may also alter product perception. As the tariff environment continues to evolve, companies will need a balanced approach that combines cost management with transparent communication of value propositions.

Unpacking Core Market Segments Driving Demand

Dissecting the market through the lens of product type reveals a tripartite structure encompassing dietary supplements, functional beverages, and functional foods. Within dietary supplements, demand for amino acids and enzymes is fueled by sports nutrition, while an expanding base of health-conscious consumers drives growth in herbal supplements, minerals, and vitamins. Functional beverages span dairy-based beverages, energy drinks, fortified juices, and sports drinks, each responding to distinct usage occasions ranging from post-workout recovery to on-the-go wellness. Functional foods include fortified foods enriched with micronutrients, omega-3 enriched foods catering to heart health, and probiotic foods supporting gut balance.

Forms play a pivotal role in consumer adoption, with bars, capsules, gummies, liquids, powders, soft gels, and tablets each competing for shelf space and mindshare. Gummies and soft gels appeal to younger demographics seeking convenience and palatability, whereas powders and capsules attract performance-oriented users focused on precise dosing. The choice of source-animal-based, marine-based, microbial-based, or plant-based-further influences positioning and price tiers. Plant-based extracts resonate with clean-label advocates, while microbial fermentation remains a cost-effective route to bioactive compounds.

Applications span digestive health, where prebiotics and probiotics retain a loyal following; mental health, buoyed by cognitive boosters and mood enhancers; sports nutrition, with pre-workout blends, protein supplements, and recovery drinks driving daily routines; and weight management, anchored by appetite suppressants and meal replacements. End-users range from professional athletes and fitness enthusiasts to everyday individual consumers and institutional buyers catering to clinical or sports facilities. Distribution channels bifurcate into offline networks-pharmacies, drugstores, supermarkets, hypermarkets-and online platforms comprising brand websites and third-party e-commerce marketplaces. Each segmentation dimension offers unique growth levers, underscoring the need for precision marketing and tailored go-to-market tactics.

Regional Dynamics Shaping Growth Trajectories

In the Americas, robust consumer spending on wellness continues to underpin growth, as public health initiatives and favorable reimbursement environments boost supplement uptake. North American markets lead in both product innovation and digital penetration, while Latin American countries are emerging as hotspots for value-oriented formulations.

Across Europe, Middle East & Africa, regulatory harmonization efforts and heightened scrutiny around health claims are reshaping product development. Western European nations exhibit strong demand for clean-label, certified-organic offerings, whereas Middle Eastern markets favor fortified beverages that address regional nutritional deficiencies. African markets, though nascent, present long-term opportunities tied to urbanization and rising disposable incomes.

Asia-Pacific stands out for its rapid adoption of traditional and modern nutraceuticals alike. Japan and South Korea drive functional food innovation, leveraging local botanical heritage, while China’s expanding middle class fuels volume growth in functional beverages and weight management solutions. Southeast Asian markets are witnessing a surge in digital-first brands that target millennial health enthusiasts.

Strategic Movements from Leading Nutraceutical Players

Leading companies are forging diversified portfolios to address evolving consumer needs. Multinational conglomerates are expanding through strategic acquisitions of niche supplement brands, integrating botanical innovation into their existing pipelines. At the same time, specialized players are forging alliances with research institutions to co-develop next-generation ingredients such as novel prebiotic fibers and marine-derived bioactives.

Mergers and partnerships are accelerating consolidation, particularly among mid-sized regional manufacturers seeking scale in production and distribution. Several prominent firms have also invested in cutting-edge manufacturing facilities that blend enzymatic synthesis with clean-room standards, ensuring both potency and safety. Meanwhile, digital natives are leveraging direct-to-consumer models to build branded ecosystems around personalized nutrition and subscription channels.

Innovation in delivery systems remains a key battleground. Companies are rolling out sustained-release soft gels and microencapsulated powders designed for optimized absorption. At the same time, collaborations with tech startups are enabling real-time monitoring of compliance and efficacy through wearable devices and mobile applications. These strategic moves reflect a broader trend toward integrated health solutions that extend well beyond single-ingredient offerings.

Actionable Strategies for Industry Leadership

To thrive amid intensifying competition and regulatory complexity, industry leaders should prioritize a dual approach that balances cost optimization with innovation. First, investing in flexible, modular manufacturing lines will allow rapid reformulation in response to tariff adjustments and emerging ingredient trends. By designing facilities capable of handling both microbial-based fermentation and plant-based extraction, organizations can pivot quickly to maintain supply continuity and protect margins.

Second, building robust data analytics capabilities across R&D, marketing, and distribution functions can unlock insights into consumer preferences and usage patterns. Integrating digital platforms with direct-to-consumer initiatives will not only drive recurring revenue but also generate invaluable feedback loops that inform product development. Collaboration with healthcare professionals and academic institutions can further validate claims and strengthen brand credibility.

Third, companies should adopt a regionally nuanced portfolio strategy. Tailoring formulations to local taste profiles and regulatory requirements-be it probiotic yogurt blends in Europe or fortified tea infusions in Asia-Pacific-will resonate more effectively with diverse audiences. Strategic alliances with regional distributors will accelerate market entry and enhance last-mile logistics, especially in emerging markets where offline and online channels intersect.

Finally, sustainability must move from rhetoric to reality. Implementing transparent sourcing policies, reducing packaging waste, and investing in carbon-neutral operations will not only meet consumer expectations but also preempt tightening environmental regulations.

Robust Methodology Underpinning Market Insights

Our findings rest on a comprehensive methodology that combines rigorous primary and secondary research. An extensive series of interviews with executives from ingredient suppliers, contract manufacturers, and brand owners provided qualitative insights into strategic priorities and operational challenges. This primary research was complemented by expert discussions with regulatory authorities and healthcare professionals to contextualize emerging safety and compliance trends.

Secondary data sources included proprietary trade databases, financial reports, and peer-reviewed scientific literature. Statistical analysis of import-export volumes, tariff schedules, and patent filings enriched our understanding of supply chain dynamics and innovation trajectories. A triangulation approach ensured that quantitative findings were cross-validated against firsthand accounts from industry stakeholders.

The market was segmented across product type, form, source, application, end-user, and distribution channel to deliver granular insights. Regional analyses considered socioeconomic indicators, public health policies, and consumer behavior patterns to map growth hotspots. Throughout the process, our team maintained strict data governance protocols and adhered to ethical guidelines to guarantee the integrity and reliability of the research.

Synthesizing Key Takeaways for Decision Makers

This executive summary has outlined the multifaceted transformation of the nutraceutical sector, driven by consumer empowerment, technological breakthroughs, and shifting regulatory landscapes. We have examined the ripple effects of United States tariffs, illuminated critical market segments, and spotlighted regional nuances that will define the next phase of growth. By analyzing strategic initiatives of leading players and distilling actionable recommendations, this overview equips decision-makers with a clear roadmap.

As organizations navigate an arena marked by rapid evolution and heightened expectations, informed agility becomes paramount. Whether adjusting to new tariff regimes, customizing products for local tastes, or embracing sustainability as a core value, the ability to anticipate and respond to change will separate market leaders from followers.

For those seeking a deeper dive into granular data, competitive benchmarking, and tactical frameworks, the full market research report offers an indispensable resource. It provides the detailed tables, charts, and scenario analyses necessary to drive confident investment and guide long-term strategy.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Product Type
    • Dietary Supplements
      • Amino Acids
      • Enzymes
      • Herbal Supplements
      • Minerals
      • Vitamins
    • Functional Beverages
      • Dairy-based Beverages
      • Energy Drinks
      • Fortified Juices
      • Sports Drinks
    • Functional Foods
      • Fortified Foods
      • Omega-3 Enriched Foods
      • Probiotic Foods
  • Form
    • Bars
    • Capsules
    • Gummies
    • Liquids
    • Powders
    • Soft Gels
    • Tablets
  • Source
    • Animal-based
    • Marine-based
    • Microbial-based
    • Plant-based
  • Application
    • Digestive Health
      • Prebiotics
      • Probiotics
    • Mental Health
      • Cognitive Boosters
      • Mood Enhancers
    • Sports Nutrition
      • Pre-Workout
      • Protein Supplements
      • Recovery Drinks
    • Weight Management
      • Appetite Suppressants
      • Meal Replacements
  • End-User
    • Athletes & Fitness Enthusiasts
    • Individual Use
    • Institutional
  • Distribution Channel
    • Offline
      • Pharmacies/Drugstores
      • Supermarkets/Hypermarkets
    • Online
      • Brands Website
      • E-commmerce Platform
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • Ajinomoto Co., Inc.
  • Amway Corporation
  • Archer Daniels Midland Company
  • Associated British Foods PLC
  • Balchem Corporation
  • Barentz International B.V.
  • BASF SE
  • Bayer AG
  • BIONAP S.R.L.
  • Cargill Incorporated
  • Chr. Hansen Holding A/S
  • Divi's Laboratories Limited
  • DSM-Firmenich AG
  • DuPont de Nemours, Inc.
  • Fonterra Co-Operative Group Limited
  • Glanbia PLC
  • Ingredion Incorporated
  • Jamieson Wellness Inc.
  • Kerry Group PLC
  • Kyowa Hakko USA, Inc.
  • Lonza Group Ltd
  • Martin Bauer Group
  • Nestle S.A.
  • Nutricia by Danone S.A.
  • Pfizer Inc.
  • Sydler India Pvt. Ltd.
  • ZIVO Bioscience, Inc.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
3.1. Detailed analysis of nutraceuticals market's current position and its evolving cross-industry significance
3.2. Quantitative study of consumer drivers and strategic evaluation of standardized versus localized product approaches
3.3. Comprehensive market lifecycle evaluation and intellectual property landscape review with strategic go-to-market roadmap
3.4. Forward-looking market outlook with growth opportunities and emerging technological trends in nutraceuticals
4. Market Overview
4.1. Introduction
4.1.1. Comprehensive definition of the nutraceuticals market with global economic significance, main growth drivers, emerging opportunities, and strategic recommendations for industry advancement
4.1.2. In-depth evaluation of regional nutraceutical markets including Americas, EMEA, and Asia-Pacific with insights on trade dynamics and cultural-economic influences
4.1.3. Summary of recent patents, research breakthroughs, investments, and industry events shaping the nutraceuticals market landscape from 2023 to 2025
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Expansion of the anti-aging and cognitive health nutraceutical market
5.1.1. Defining the expansion of the anti-aging and cognitive health nutraceutical market and its key drivers
5.1.2. How the expansion of the anti-aging and cognitive health nutraceutical market is transforming innovation and business opportunities
5.1.3. Future trajectory of the anti-aging and cognitive health nutraceutical market with strategic considerations
5.2. Collaborations between pharmaceutical and nutraceutical companies accelerating product development
5.2.1. Defining the trend of collaborations between pharmaceutical and nutraceutical companies in product development and its market significance
5.2.2. Analyzing the impact of pharmaceutical and nutraceutical collaborations on market innovation demand and growth opportunities
5.2.3. Exploring the future trajectory and strategic considerations for pharmaceutical nutraceutical collaborations in the market
5.3. Expansion of immune-boosting nutraceuticals amid global health concerns
5.3.1. Clear articulation of what the expansion of immune-boosting nutraceuticals means and key market drivers behind this trend
5.3.2. How companies should adapt strategically to the immune-boosting nutraceuticals trend reshaping market dynamics and consumer expectations
5.3.3. Projected evolution and long-term strategic considerations for immune-boosting nutraceuticals amid ongoing health awareness
5.4. Increasing adoption of sustainable packaging in the nutraceutical industry
5.4.1. Clearly articulate what the trend means for the market and key drivers accelerating its adoption in the nutraceutical industry
5.4.2. Explain how companies operating in the nutraceutical market should adapt strategically to the increasing demand for sustainable packaging and the resulting shifts in competitive dynamics and operational challenges
5.4.3. Evaluate the projected evolution of sustainable packaging adoption in the nutraceutical industry and its strategic implications for market participants over the next several years
5.5. Digital health technologies enabling personalized nutraceutical recommendations
5.5.1. Defining digital health technologies enabling personalized nutraceutical recommendations and their market significance
5.5.2. How digital health technologies personalizing nutraceutical recommendations transform the market and drive new growth opportunities
5.5.3. Future trajectory of digital health-enabled personalized nutraceutical recommendations with implications and challenges
5.6. The impact of clean label trends on nutraceutical ingredient sourcing
5.6.1. Understanding the meaning and key drivers behind the clean label trend impacting nutraceutical ingredient sourcing
5.6.2. Adapting business strategies to meet clean label ingredient sourcing demands and reshaping market dynamics
5.6.3. Projecting the evolution and strategic implications of clean label trends in nutraceutical ingredient sourcing
5.7. Integration of biotechnology enhancing efficacy of nutraceutical formulations
5.7.1. Clearly articulate what the trend means in for the market and key factors are acting as drivers for this trend Explain why is this trend gaining momentum now in this specific market
5.7.2. Explain how companies operating in this market should adapt to the emerging trend What strategic adjustments are necessary to stay competitive Describe how the trend is reshaping business decisions customer expectations and operational challenges Highlight how it is influencing competitive dynamics lowering or raising barriers to entry and driving new forms of collaboration across the industry
5.7.3. Evaluate the likely evolution of this trend over the next 3-5 years within this market Will it intensify stabilize merge with other trends or face decline What are the key long-term strategic considerations for players in the Market related to this trend
5.8. The growth of cognitive health supplements fueled by consumer awareness
5.8.1. Understanding The Rise Of Cognitive Health Supplements Through Increased Consumer Awareness
5.8.2. Transforming Market Landscape And Unlocking New Growth Opportunities For Cognitive Health Supplements
5.8.3. Future Trajectory Long-Term Implications And Strategic Considerations For The Cognitive Health Supplements Market
5.9. Advancements in personalized nutrition driving nutraceutical innovation
5.9.1. Understanding advances in personalized nutrition and its key characteristics within nutraceutical market dynamics
5.9.2. Transforming the nutraceutical landscape through personalized nutrition enabling innovation and market expansion
5.9.3. Anticipating the future trajectory and strategic considerations for personalized nutrition in nutraceuticals
5.10. The rising demand for plant-based nutraceutical products among millennials
5.10.1. Comprehensive definition and driving factors behind the growing preference for plant-based nutraceutical products among millennials
5.10.2. How the rise of plant-based nutraceutical preference among millennials is fostering market innovation and opportunities
5.10.3. Future trajectory and strategic considerations for leveraging millennial-driven plant-based nutraceutical demand
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.1.1. Evaluation of barriers like capital requirements and regulatory challenges shaping the threat of new entrants in nutraceuticals market
6.1.2. Assessment of alternative products and evolving consumer preferences influencing the threat of substitutes in nutraceuticals
6.1.3. Analysis of concentrated suppliers and unique inputs affecting the bargaining power of suppliers in nutraceuticals market
6.1.4. Examination of buyer concentration and price sensitivity intensifying bargaining power of buyers in nutraceuticals
6.1.5. Investigation of extensive competition and innovation intensifying industry rivalry in nutraceuticals market
6.2. PESTLE Analysis
6.2.1. Political factors shaping regulatory frameworks and trade policies critical for the nutraceuticals market
6.2.2. Economic trends influencing consumer spending power and cost dynamics in the nutraceuticals market
6.2.3. Social trends driving demand for preventive health and ethical consumption in nutraceuticals
6.2.4. Technological innovations enhancing product development and personalized nutrition solutions in nutraceuticals
6.2.5. Legal regulations enforcing compliance and intellectual property protection crucial for nutraceuticals
6.2.6. Environmental sustainability and resource management shaping the future of the nutraceuticals market
7. Cumulative Impact of United States Tariffs 2025
7.1. An overview of notable tariffs implemented by the United States on the market from 2023 to 2025 with major tariffs explained including rates and timelines
7.2. A discussion of the historical background of United States tariff policies and their intended economic rationale from 2018 to 2025 on developed and developing countries
7.3. An analysis of how recent tariff implementations have directly contributed to inflation in the global economy with data and statistics to illustrate these effects
7.4. An examination of the implications of reciprocal tariffs between the United States and its trading partners across regions highlighting trade wars and the geopolitical context
7.5. An evaluation of the economic and political consequences of United States tariffs on major trading partners including immediate and long-term effects
7.6. An identification of long-term structural changes in the United States economy arising due to tariff policies including shifts in supply chains and consumer purchasing behavior
7.7. Suggested potential policy responses and strategies to mitigate negative impacts of tariffs on the United States economy and its trading partners
8. Nutraceuticals Market, by Product Type
8.1. Introduction
8.2. Dietary Supplements
8.2.1. Amino Acids
8.2.2. Enzymes
8.2.3. Herbal Supplements
8.2.4. Minerals
8.2.5. Vitamins
8.3. Functional Beverages
8.3.1. Dairy-based Beverages
8.3.2. Energy Drinks
8.3.3. Fortified Juices
8.3.4. Sports Drinks
8.4. Functional Foods
8.4.1. Fortified Foods
8.4.2. Omega-3 Enriched Foods
8.4.3. Probiotic Foods
9. Nutraceuticals Market, by Form
9.1. Introduction
9.2. Bars
9.3. Capsules
9.4. Gummies
9.5. Liquids
9.6. Powders
9.7. Soft Gels
9.8. Tablets
10. Nutraceuticals Market, by Source
10.1. Introduction
10.2. Animal-based
10.3. Marine-based
10.4. Microbial-based
10.5. Plant-based
11. Nutraceuticals Market, by Application
11.1. Introduction
11.2. Digestive Health
11.2.1. Prebiotics
11.2.2. Probiotics
11.3. Mental Health
11.3.1. Cognitive Boosters
11.3.2. Mood Enhancers
11.4. Sports Nutrition
11.4.1. Pre-Workout
11.4.2. Protein Supplements
11.4.3. Recovery Drinks
11.5. Weight Management
11.5.1. Appetite Suppressants
11.5.2. Meal Replacements
12. Nutraceuticals Market, by End-User
12.1. Introduction
12.2. Athletes & Fitness Enthusiasts
12.3. Individual Use
12.4. Institutional
13. Nutraceuticals Market, by Distribution Channel
13.1. Introduction
13.2. Offline
13.2.1. Pharmacies/Drugstores
13.2.2. Supermarkets/Hypermarkets
13.3. Online
13.3.1. Brands Website
13.3.2. E-commmerce Platform
14. Americas Nutraceuticals Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Nutraceuticals Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Nutraceuticals Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Ajinomoto Co., Inc.
17.3.1.1. Comprehensive overview of Ajinomoto Co., Inc.’s market entry strategy, evolution, and current competitive positioning
17.3.1.2. In-depth exploration of Ajinomoto Co., Inc.’s flagship nutraceutical products, their features, and unique market differentiation
17.3.1.3. Thorough analysis of risks, current challenges, and strategic recommendations for Ajinomoto Co., Inc.’s sustained growth and competitive advantage
17.3.2. Amway Corporation
17.3.2.1. How Amway Corporation entered the nutraceutical market and its current strategic market positioning and competitive standing
17.3.2.2. Detailed features and unique selling propositions of Amway's flagship Nutrilite nutraceutical products and how they meet consumer needs
17.3.2.3. Risks, vulnerabilities, and actionable strategies to reinforce Amway’s competitive position and growth in the evolving nutraceuticals market
17.3.3. Archer Daniels Midland Company
17.3.3.1. Comprehensive overview of Archer Daniels Midland Company's strategic market positioning and growth milestones in nutraceuticals
17.3.3.2. Detailed analysis of Archer Daniels Midland Company's flagship nutraceutical products addressing consumer needs and competitive advantages
17.3.3.3. In-depth identification of strategic risks and actionable growth strategies for Archer Daniels Midland Company within the evolving nutraceutical industry
17.3.4. Associated British Foods PLC
17.3.4.1. Comprehensive overview of Associated British Foods PLC's strategic positioning and market presence across regions and milestones
17.3.4.2. Detailed analysis of flagship nutraceutical products and their unique value propositions in meeting modern consumer demands
17.3.4.3. Thorough evaluation of risks and strategic recommendations for enhancing product innovation and market growth
17.3.5. Balchem Corporation
17.3.5.1. Comprehensive overview of Balchem Corporation’s market role strategic positioning and core strengths within the nutraceuticals landscape
17.3.5.2. In-depth analysis of Balchem Corporation’s flagship products their features and market alignment to consumer needs in nutraceuticals
17.3.5.3. Critical evaluation of risks and actionable strategies to enhance Balchem Corporation’s product portfolio and market growth potential in the evolving nutraceutical sector
17.3.6. Barentz International B.V.
17.3.6.1. Comprehensive overview of Barentz International B.V.'s strategic market positioning and core strengths in nutraceuticals
17.3.6.2. In-depth analysis of Barentz International B.V.'s flagship products and unique selling propositions in the nutraceutical sector
17.3.6.3. Strategic evaluation of risks and actionable growth strategies for Barentz International B.V. in the evolving nutraceutical market
17.3.7. BASF SE
17.3.7.1. An in-depth overview of BASF SE's strategic positioning, major strengths, and geographic influence in the nutraceutical market
17.3.7.2. Comprehensive analysis of BASF SE's flagship nutraceutical products, highlighting features, consumer alignment, and unique selling propositions
17.3.7.3. Critical analysis of risks to BASF SE's growth in nutraceuticals, with strategic recommendations for portfolio enhancement and market expansion
17.3.8. Bayer AG
17.3.8.1. Comprehensive overview of Bayer AG’s strategic positioning, market presence, and core strengths in nutraceuticals
17.3.8.2. In-depth analysis of Bayer AG’s flagship nutraceutical products highlighting key features and unique selling points
17.3.8.3. Critical analysis of potential risks and strategic opportunities for Bayer AG to enhance growth and product portfolio in nutraceuticals
17.3.9. BIONAP S.R.L.
17.3.9.1. A focused overview of BIONAP S.R.L.'s strategic positioning major strengths and market presence in nutraceuticals
17.3.9.2. Detailed analysis of BIONAP S.R.L.'s flagship nutraceutical products and their alignment with target market needs
17.3.9.3. Identification of risks to BIONAP S.R.L.'s growth and strategies for product portfolio enhancement and market expansion
17.3.10. Cargill Incorporated
17.3.10.1. Comprehensive overview of Cargill Incorporated's strategic positioning and market presence in nutraceuticals
17.3.10.2. In-depth analysis of Cargill Incorporated's flagship products addressing key consumer needs in nutraceuticals
17.3.10.3. Critical evaluation of risks and strategic pathways for Cargill Incorporated to enhance growth and innovation in nutraceuticals
17.3.11. Chr. Hansen Holding A/S
17.3.11.1. In-depth overview of Chr. Hansen Holding A/S's current strategic position and market establishment with global reach
17.3.11.2. Comprehensive analysis of Chr. Hansen Holding A/S's flagship probiotic, enzyme, and natural color products tailored to nutraceutical market needs
17.3.11.3. Critical assessment of risks and strategic recommendations for enhancing Chr. Hansen Holding A/S's growth and market resilience
17.3.12. Divi's Laboratories Limited
17.3.12.1. In-depth overview of Divi's Laboratories Limited market entry, strategic evolution, and competitive landscape positioning
17.3.12.2. Comprehensive analysis of Divi's Laboratories flagship products, key features, and market differentiation strategies
17.3.12.3. Critical evaluation of risks, vulnerabilities, and strategic actions to enhance Divi's Laboratories future growth and competitiveness
17.3.13. DSM-Firmenich AG
17.3.13.1. Comprehensive overview of DSM-Firmenich AG’s strategic positioning and core strengths in the nutraceutical market
17.3.13.2. In-depth analysis of DSM-Firmenich AG’s flagship nutraceutical products and their unique market propositions
17.3.13.3. Identification of potential risks to DSM-Firmenich AG’s growth with strategic recommendations for market leadership and portfolio enhancement
17.3.14. DuPont de Nemours, Inc.
17.3.14.1. A focused overview of DuPont de Nemours' current strategic positioning and market presence in nutraceuticals
17.3.14.2. An in-depth analysis of DuPont de Nemours' flagship nutraceutical offerings and their alignment with market demands
17.3.14.3. Identifying risks and actionable strategies for DuPont de Nemours to enhance growth and innovation in nutraceuticals
17.3.15. Fonterra Co-Operative Group Limited
17.3.15.1. Detailed Overview of Fonterra's Market Entry, Strategic Evolution, and Current Positioning in Nutraceuticals
17.3.15.2. In-Depth Analysis of Fonterra's Flagship Nutraceutical Products Addressing Consumer Needs
17.3.15.3. Comprehensive Evaluation of Risks, Weaknesses, and Strategic Recommendations for Fonterra's Sustained Growth
17.3.16. Glanbia PLC
17.3.16.1. An In-Depth Review of Glanbia PLC's Strategic Position and Market Presence in Nutraceuticals Industry
17.3.16.2. Comprehensive Analysis of Glanbia PLC's Flagship Nutraceutical Products and Their Market Alignment
17.3.16.3. Strategic Risk Analysis and Actionable Growth Strategies for Glanbia PLC in the Evolving Nutraceutical Market
17.3.17. Ingredion Incorporated
17.3.17.1. Comprehensive overview of Ingredion Incorporated’s strategic market role strengths and geographic influence
17.3.17.2. Detailed analysis of Ingredion Incorporated’s flagship products and unique selling propositions aligned with consumer needs
17.3.17.3. In-depth evaluation of growth risks challenges and strategic opportunities for Ingredion Incorporated’s future market leadership
17.3.18. Jamieson Wellness Inc.
17.3.18.1. Comprehensive overview of Jamieson Wellness Inc.s market entry initial strategy key milestones current market positioning and competitive standing
17.3.18.2. In-depth analysis of Jamieson Wellness Inc.s flagship product portfolio key features and unique selling propositions
17.3.18.3. Evaluation of significant risks vulnerabilities and strategic recommendations for Jamieson Wellness Inc.s growth and market stability
17.3.19. Kerry Group PLC
17.3.19.1. Comprehensive overview of Kerry Group PLC's market entry evolution and current strategic positioning in the nutraceutical sector
17.3.19.2. In-depth examination of Kerry Group PLC's flagship nutraceutical products and distinct value propositions they provide to target customers
17.3.19.3. Critical analysis of potential risks Kerry Group PLC faces with actionable strategies to enhance growth and competitive advantage in the nutraceutical market
17.3.20. Kyowa Hakko USA, Inc.
17.3.20.1. Comprehensive overview of Kyowa Hakko USA's market presence, strategic positioning, and core strengths in the nutraceutical sector
17.3.20.2. In-depth analysis of Kyowa Hakko USA's flagship amino acid products and their alignment with customer needs
17.3.20.3. Strategic risk assessment and forward-looking growth strategies for Kyowa Hakko USA in the evolving nutraceutical market
17.3.21. Lonza Group Ltd
17.3.21.1. Lonza Group Ltd's current strategic market role, core strength, and geographic influence with significant milestones
17.3.21.2. Comprehensive analysis of Lonza Group Ltd's flagship products and services tailored for the nutraceutical market with their unique selling points
17.3.21.3. Key risks and actionable strategies for Lonza Group Ltd to enhance its product portfolio and market position by leveraging emerging trends and diversification
17.3.22. Martin Bauer Group
17.3.22.1. Comprehensive overview of Martin Bauer Group's strategic positioning and market presence revealing core strengths and recent developments
17.3.22.2. In-depth analysis of Martin Bauer Group's flagship botanical extracts highlighting features and differentiation in the nutraceutical market
17.3.22.3. Strategic risk assessment and actionable growth strategies to strengthen Martin Bauer Group’s market position and product portfolio
17.3.23. Nestle S.A.
17.3.23.1. Detailed overview of Nestle S.A.'s market entry strategy, milestones, and current market positioning with competitive landscape and geographic reach
17.3.23.2. Comprehensive examination of Nestle S.A.'s flagship nutraceutical products featuring unique selling points and consumer value propositions
17.3.23.3. In-depth evaluation of potential risks to Nestle S.A.'s nutraceutical growth with recommended strategic initiatives for resilience and innovation
17.3.24. Nutricia by Danone S.A.
17.3.24.1. Comprehensive overview of Nutricia’s strategic position, market role, and core strengths in nutraceuticals
17.3.24.2. In-depth analysis of Nutricia’s flagship nutraceutical products and their alignment with consumer health needs
17.3.24.3. Strategic risk analysis with actionable growth strategies for Nutricia in the evolving nutraceutical market
17.3.25. Pfizer Inc.
17.3.25.1. Comprehensive Overview of Pfizer's Entry, Evolution, and Current Strategic Position in the Nutraceutical Market
17.3.25.2. In-Depth Examination of Pfizer's Flagship Nutraceutical Products with Unique Selling Propositions Aligned to Consumer Needs
17.3.25.3. Identification of Key Risks and Tailored Strategies to Fortify Pfizer's Market Growth and Product Innovation in Nutraceuticals
17.3.26. Sydler India Pvt. Ltd.
17.3.26.1. Comprehensive overview of Sydler India Pvt. Ltd.'s strategic positioning growth milestones and geographic influence in the nutraceutical market
17.3.26.2. In-depth evaluation of Sydler India Pvt. Ltd.'s flagship nutraceutical products features and unique selling propositions aligning with consumer needs
17.3.26.3. Critical assessment of growth risks strategic initiatives and future opportunities for Sydler India Pvt Ltd in evolving nutraceutical market
17.3.27. ZIVO Bioscience, Inc.
17.3.27.1. Comprehensive overview of ZIVO Bioscience Inc’s strategic market positioning and influence within the nutraceutical sector
17.3.27.2. In-depth analysis of flagship nutritional supplements characterizing ZIVO Bioscience’s product portfolio and alignment with consumer health needs
17.3.27.3. Critical examination of strategic risks and actionable growth strategies for ZIVO Bioscience in evolving nutraceutical markets
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. NUTRACEUTICALS MARKET MULTI-CURRENCY
FIGURE 2. NUTRACEUTICALS MARKET MULTI-LANGUAGE
FIGURE 3. NUTRACEUTICALS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL NUTRACEUTICALS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL NUTRACEUTICALS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL NUTRACEUTICALS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL NUTRACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL NUTRACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL NUTRACEUTICALS MARKET SIZE, BY FORM, 2024 VS 2030 (%)
FIGURE 10. GLOBAL NUTRACEUTICALS MARKET SIZE, BY FORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL NUTRACEUTICALS MARKET SIZE, BY SOURCE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL NUTRACEUTICALS MARKET SIZE, BY SOURCE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL NUTRACEUTICALS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL NUTRACEUTICALS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL NUTRACEUTICALS MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
FIGURE 16. GLOBAL NUTRACEUTICALS MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 18. GLOBAL NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS NUTRACEUTICALS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS NUTRACEUTICALS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES NUTRACEUTICALS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES NUTRACEUTICALS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA NUTRACEUTICALS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA NUTRACEUTICALS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC NUTRACEUTICALS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC NUTRACEUTICALS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. NUTRACEUTICALS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. NUTRACEUTICALS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. NUTRACEUTICALS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL NUTRACEUTICALS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL NUTRACEUTICALS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL NUTRACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL NUTRACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL NUTRACEUTICALS MARKET SIZE, BY DIETARY SUPPLEMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL NUTRACEUTICALS MARKET SIZE, BY AMINO ACIDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL NUTRACEUTICALS MARKET SIZE, BY ENZYMES, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL NUTRACEUTICALS MARKET SIZE, BY HERBAL SUPPLEMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL NUTRACEUTICALS MARKET SIZE, BY MINERALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL NUTRACEUTICALS MARKET SIZE, BY VITAMINS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL NUTRACEUTICALS MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL NUTRACEUTICALS MARKET SIZE, BY FUNCTIONAL BEVERAGES, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL NUTRACEUTICALS MARKET SIZE, BY DAIRY-BASED BEVERAGES, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL NUTRACEUTICALS MARKET SIZE, BY ENERGY DRINKS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL NUTRACEUTICALS MARKET SIZE, BY FORTIFIED JUICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL NUTRACEUTICALS MARKET SIZE, BY SPORTS DRINKS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL NUTRACEUTICALS MARKET SIZE, BY FUNCTIONAL BEVERAGES, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL NUTRACEUTICALS MARKET SIZE, BY FUNCTIONAL FOODS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL NUTRACEUTICALS MARKET SIZE, BY FORTIFIED FOODS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL NUTRACEUTICALS MARKET SIZE, BY OMEGA-3 ENRICHED FOODS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL NUTRACEUTICALS MARKET SIZE, BY PROBIOTIC FOODS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL NUTRACEUTICALS MARKET SIZE, BY FUNCTIONAL FOODS, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL NUTRACEUTICALS MARKET SIZE, BY BARS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL NUTRACEUTICALS MARKET SIZE, BY CAPSULES, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL NUTRACEUTICALS MARKET SIZE, BY GUMMIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL NUTRACEUTICALS MARKET SIZE, BY LIQUIDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL NUTRACEUTICALS MARKET SIZE, BY POWDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL NUTRACEUTICALS MARKET SIZE, BY SOFT GELS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL NUTRACEUTICALS MARKET SIZE, BY TABLETS, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL NUTRACEUTICALS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL NUTRACEUTICALS MARKET SIZE, BY ANIMAL-BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL NUTRACEUTICALS MARKET SIZE, BY MARINE-BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL NUTRACEUTICALS MARKET SIZE, BY MICROBIAL-BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL NUTRACEUTICALS MARKET SIZE, BY PLANT-BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL NUTRACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL NUTRACEUTICALS MARKET SIZE, BY DIGESTIVE HEALTH, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL NUTRACEUTICALS MARKET SIZE, BY PREBIOTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL NUTRACEUTICALS MARKET SIZE, BY PROBIOTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL NUTRACEUTICALS MARKET SIZE, BY DIGESTIVE HEALTH, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL NUTRACEUTICALS MARKET SIZE, BY MENTAL HEALTH, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL NUTRACEUTICALS MARKET SIZE, BY COGNITIVE BOOSTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL NUTRACEUTICALS MARKET SIZE, BY MOOD ENHANCERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL NUTRACEUTICALS MARKET SIZE, BY MENTAL HEALTH, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL NUTRACEUTICALS MARKET SIZE, BY SPORTS NUTRITION, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL NUTRACEUTICALS MARKET SIZE, BY PRE-WORKOUT, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL NUTRACEUTICALS MARKET SIZE, BY PROTEIN SUPPLEMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL NUTRACEUTICALS MARKET SIZE, BY RECOVERY DRINKS, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL NUTRACEUTICALS MARKET SIZE, BY SPORTS NUTRITION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL NUTRACEUTICALS MARKET SIZE, BY WEIGHT MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL NUTRACEUTICALS MARKET SIZE, BY APPETITE SUPPRESSANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL NUTRACEUTICALS MARKET SIZE, BY MEAL REPLACEMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL NUTRACEUTICALS MARKET SIZE, BY WEIGHT MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL NUTRACEUTICALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL NUTRACEUTICALS MARKET SIZE, BY ATHLETES & FITNESS ENTHUSIASTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL NUTRACEUTICALS MARKET SIZE, BY INDIVIDUAL USE, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL NUTRACEUTICALS MARKET SIZE, BY INSTITUTIONAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL NUTRACEUTICALS MARKET SIZE, BY OFFLINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL NUTRACEUTICALS MARKET SIZE, BY PHARMACIES/DRUGSTORES, BY REGION, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL NUTRACEUTICALS MARKET SIZE, BY SUPERMARKETS/HYPERMARKETS, BY REGION, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL NUTRACEUTICALS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 65. GLOBAL NUTRACEUTICALS MARKET SIZE, BY ONLINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 66. GLOBAL NUTRACEUTICALS MARKET SIZE, BY BRANDS WEBSITE, BY REGION, 2018-2030 (USD MILLION)
TABLE 67. GLOBAL NUTRACEUTICALS MARKET SIZE, BY E-COMMMERCE PLATFORM, BY REGION, 2018-2030 (USD MILLION)
TABLE 68. GLOBAL NUTRACEUTICALS MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 69. AMERICAS NUTRACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 70. AMERICAS NUTRACEUTICALS MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2030 (USD MILLION)
TABLE 71. AMERICAS NUTRACEUTICALS MARKET SIZE, BY FUNCTIONAL BEVERAGES, 2018-2030 (USD MILLION)
TABLE 72. AMERICAS NUTRACEUTICALS MARKET SIZE, BY FUNCTIONAL FOODS, 2018-2030 (USD MILLION)
TABLE 73. AMERICAS NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 74. AMERICAS NUTRACEUTICALS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 75. AMERICAS NUTRACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 76. AMERICAS NUTRACEUTICALS MARKET SIZE, BY DIGESTIVE HEALTH, 2018-2030 (USD MILLION)
TABLE 77. AMERICAS NUTRACEUTICALS MARKET SIZE, BY MENTAL HEALTH, 2018-2030 (USD MILLION)
TABLE 78. AMERICAS NUTRACEUTICALS MARKET SIZE, BY SPORTS NUTRITION, 2018-2030 (USD MILLION)
TABLE 79. AMERICAS NUTRACEUTICALS MARKET SIZE, BY WEIGHT MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 80. AMERICAS NUTRACEUTICALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 81. AMERICAS NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 82. AMERICAS NUTRACEUTICALS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 83. AMERICAS NUTRACEUTICALS MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 84. AMERICAS NUTRACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 85. UNITED STATES NUTRACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 86. UNITED STATES NUTRACEUTICALS MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2030 (USD MILLION)
TABLE 87. UNITED STATES NUTRACEUTICALS MARKET SIZE, BY FUNCTIONAL BEVERAGES, 2018-2030 (USD MILLION)
TABLE 88. UNITED STATES NUTRACEUTICALS MARKET SIZE, BY FUNCTIONAL FOODS, 2018-2030 (USD MILLION)
TABLE 89. UNITED STATES NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 90. UNITED STATES NUTRACEUTICALS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 91. UNITED STATES NUTRACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 92. UNITED STATES NUTRACEUTICALS MARKET SIZE, BY DIGESTIVE HEALTH, 2018-2030 (USD MILLION)
TABLE 93. UNITED STATES NUTRACEUTICALS MARKET SIZE, BY MENTAL HEALTH, 2018-2030 (USD MILLION)
TABLE 94. UNITED STATES NUTRACEUTICALS MARKET SIZE, BY SPORTS NUTRITION, 2018-2030 (USD MILLION)
TABLE 95. UNITED STATES NUTRACEUTICALS MARKET SIZE, BY WEIGHT MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 96. UNITED STATES NUTRACEUTICALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 97. UNITED STATES NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 98. UNITED STATES NUTRACEUTICALS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 99. UNITED STATES NUTRACEUTICALS MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 100. UNITED STATES NUTRACEUTICALS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 101. CANADA NUTRACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 102. CANADA NUTRACEUTICALS MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2030 (USD MILLION)
TABLE 103. CANADA NUTRACEUTICALS MARKET SIZE, BY FUNCTIONAL BEVERAGES, 2018-2030 (USD MILLION)
TABLE 104. CANADA NUTRACEUTICALS MARKET SIZE, BY FUNCTIONAL FOODS, 2018-2030 (USD MILLION)
TABLE 105. CANADA NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 106. CANADA NUTRACEUTICALS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 107. CANADA NUTRACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 108. CANADA NUTRACEUTICALS MARKET SIZE, BY DIGESTIVE HEALTH, 2018-2030 (USD MILLION)
TABLE 109. CANADA NUTRACEUTICALS MARKET SIZE, BY MENTAL HEALTH, 2018-2030 (USD MILLION)
TABLE 110. CANADA NUTRACEUTICALS MARKET SIZE, BY SPORTS NUTRITION, 2018-2030 (USD MILLION)
TABLE 111. CANADA NUTRACEUTICALS MARKET SIZE, BY WEIGHT MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 112. CANADA NUTRACEUTICALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 113. CANADA NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 114. CANADA NUTRACEUTICALS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 115. CANADA NUTRACEUTICALS MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 116. MEXICO NUTRACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 117. MEXICO NUTRACEUTICALS MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2030 (USD MILLION)
TABLE 118. MEXICO NUTRACEUTICALS MARKET SIZE, BY FUNCTIONAL BEVERAGES, 2018-2030 (USD MILLION)
TABLE 119. MEXICO NUTRACEUTICALS MARKET SIZE, BY FUNCTIONAL FOODS, 2018-2030 (USD MILLION)
TABLE 120. MEXICO NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 121. MEXICO NUTRACEUTICALS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 122. MEXICO NUTRACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 123. MEXICO NUTRACEUTICALS MARKET SIZE, BY DIGESTIVE HEALTH, 2018-2030 (USD MILLION)
TABLE 124. MEXICO NUTRACEUTICALS MARKET SIZE, BY MENTAL HEALTH, 2018-2030 (USD MILLION)
TABLE 125. MEXICO NUTRACEUTICALS MARKET SIZE, BY SPORTS NUTRITION, 2018-2030 (USD MILLION)
TABLE 126. MEXICO NUTRACEUTICALS MARKET SIZE, BY WEIGHT MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 127. MEXICO NUTRACEUTICALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 128. MEXICO NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 129. MEXICO NUTRACEUTICALS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 130. MEXICO NUTRACEUTICALS MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 131. BRAZIL NUTRACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 132. BRAZIL NUTRACEUTICALS MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2030 (USD MILLION)
TABLE 133. BRAZIL NUTRACEUTICALS MARKET SIZE, BY FUNCTIONAL BEVERAGES, 2018-2030 (USD MILLION)
TABLE 134. BRAZIL NUTRACEUTICALS MARKET SIZE, BY FUNCTIONAL FOODS, 2018-2030 (USD MILLION)
TABLE 135. BRAZIL NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 136. BRAZIL NUTRACEUTICALS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 137. BRAZIL NUTRACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 138. BRAZIL NUTRACEUTICALS MARKET SIZE, BY DIGESTIVE HEALTH, 2018-2030 (USD MILLION)
TABLE 139. BRAZIL NUTRACEUTICALS MARKET SIZE, BY MENTAL HEALTH, 2018-2030 (USD MILLION)
TABLE 140. BRAZIL NUTRACEUTICALS MARKET SIZE, BY SPORTS NUTRITION, 2018-2030 (USD MILLION)
TABLE 141. BRAZIL NUTRACEUTICALS MARKET SIZE, BY WEIGHT MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 142. BRAZIL NUTRACEUTICALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 143. BRAZIL NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 144. BRAZIL NUTRACEUTICALS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 145. BRAZIL NUTRACEUTICALS MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 146. ARGENTINA NUTRACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 147. ARGENTINA NUTRACEUTICALS MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2030 (USD MILLION)
TABLE 148. ARGENTINA NUTRACEUTICALS MARKET SIZE, BY FUNCTIONAL BEVERAGES, 2018-2030 (USD MILLION)
TABLE 149. ARGENTINA NUTRACEUTICALS MARKET SIZE, BY FUNCTIONAL FOODS, 2018-2030 (USD MILLION)
TABLE 150. ARGENTINA NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 151. ARGENTINA NUTRACEUTICALS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 152. ARGENTINA NUTRACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 153. ARGENTINA NUTRACEUTICALS MARKET SIZE, BY DIGESTIVE HEALTH, 2018-2030 (USD MILLION)
TABLE 154. ARGENTINA NUTRACEUTICALS MARKET SIZE, BY MENTAL HEALTH, 2018-2030 (USD MILLION)
TABLE 155. ARGENTINA NUTRACEUTICALS MARKET SIZE, BY SPORTS NUTRITION, 2018-2030 (USD MILLION)
TABLE 156. ARGENTINA NUTRACEUTICALS MARKET SIZE, BY WEIGHT MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 157. ARGENTINA NUTRACEUTICALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 158. ARGENTINA NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 159. ARGENTINA NUTRACEUTICALS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 160. ARGENTINA NUTRACEUTICALS MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 161. EUROPE, MIDDLE EAST & AFRICA NUTRACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 162. EUROPE, MIDDLE EAST & AFRICA NUTRACEUTICALS MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2030 (USD MILLION)
TABLE 163. EUROPE, MIDDLE EAST & AFRICA NUTRACEUTICALS MARKET SIZE, BY FUNCTIONAL BEVERAGES, 2018-2030 (USD MILLION)
TABLE 164. EUROPE, MIDDLE EAST & AFRICA NUTRACEUTICALS MARKET SIZE, BY FUNCTIONAL FOODS, 2018-2030 (USD MILLION)
TABLE 165. EUROPE, MIDDLE EAST & AFRICA NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 166. EUROPE, MIDDLE EAST & AFRICA NUTRACEUTICALS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 167. EUROPE, MIDDLE EAST & AFRICA NUTRACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 168. EUROPE, MIDDLE EAST & AFRICA NUTRACEUTICALS MARKET SIZE, BY DIGESTIVE HEALTH, 2018-2030 (USD MILLION)
TABLE 169. EUROPE, MIDDLE EAST & AFRICA NUTRACEUTICALS MARKET SIZE, BY MENTAL HEALTH, 2018-2030 (USD MILLION)
TABLE 170. EUROPE, MIDDLE EAST & AFRICA NUTRACEUTICALS MARKET SIZE, BY SPORTS NUTRITION, 2018-2030 (USD MILLION)
TABLE 171. EUROPE, MIDDLE EAST & AFRICA NUTRACEUTICALS MARKET SIZE, BY WEIGHT MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 172. EUROPE, MIDDLE EAST & AFRICA NUTRACEUTICALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 173. EUROPE, MIDDLE EAST & AFRICA NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 174. EUROPE, MIDDLE EAST & AFRICA NUTRACEUTICALS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 175. EUROPE, MIDDLE EAST & AFRICA NUTRACEUTICALS MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 176. EUROPE, MIDDLE EAST & AFRICA NUTRACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 177. UNITED KINGDOM NUTRACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 178. UNITED KINGDOM NUTRACEUTICALS MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2030 (USD MILLION)
TABLE 179. UNITED KINGDOM NUTRACEUTICALS MARKET SIZE, BY FUNCTIONAL BEVERAGES, 2018-2030 (USD MILLION)
TABLE 180. UNITED KINGDOM NUTRACEUTICALS MARKET SIZE, BY FUNCTIONAL FOODS, 2018-2030 (USD MILLION)
TABLE 181. UNITED KINGDOM NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 182. UNITED KINGDOM NUTRACEUTICALS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 183. UNITED KINGDOM NUTRACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 184. UNITED KINGDOM NUTRACEUTICALS MARKET SIZE, BY DIGESTIVE HEALTH, 2018-2030 (USD MILLION)
TABLE 185. UNITED KINGDOM NUTRACEUTICALS MARKET SIZE, BY MENTAL HEALTH, 2018-2030 (USD MILLION)
TABLE 186. UNITED KINGDOM NUTRACEUTICALS MARKET SIZE, BY SPORTS NUTRITION, 2018-2030 (USD MILLION)
TABLE 187. UNITED KINGDOM NUTRACEUTICALS MARKET SIZE, BY WEIGHT MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 188. UNITED KINGDOM NUTRACEUTICALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 189. UNITED KINGDOM NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 190. UNITED KINGDOM NUTRACEUTICALS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 191. UNITED KINGDOM NUTRACEUTICALS MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 192. GERMANY NUTRACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 193. GERMANY NUTRACEUTICALS MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2030 (USD MILLION)
TABLE 194. GERMANY NUTRACEUTICALS MARKET SIZE, BY FUNCTIONAL BEVERAGES, 2018-2030 (USD MILLION)
TABLE 195. GERMANY NUTRACEUTICALS MARKET SIZE, BY FUNCTIONAL FOODS, 2018-2030 (USD MILLION)
TABLE 196. GERMANY NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 197. GERMANY NUTRACEUTICALS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 198. GERMANY NUTRACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 199. GERMANY NUTRACEUTICALS MARKET SIZE, BY DIGESTIVE HEALTH, 2018-2030 (USD MILLION)
TABLE 200. GERMANY NUTRACEUTICALS MARKET SIZE, BY MENTAL HEALTH, 2018-2030 (USD MILLION)
TABLE 201. GERMANY NUTRACEUTICALS MARKET SIZE, BY SPORTS NUTRITION, 2018-2030 (USD MILLION)
TABLE 202. GERMANY NUTRACEUTICALS MARKET SIZE, BY WEIGHT MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 203. GERMANY NUTRACEUTICALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 204. GERMANY NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 205. GERMANY NUTRACEUTICALS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 206. GERMANY NUTRACEUTICALS MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 207. FRANCE NUTRACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 208. FRANCE NUTRACEUTICALS MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2030 (USD MILLION)
TABLE 209. FRANCE NUTRACEUTICALS MARKET SIZE, BY FUNCTIONAL BEVERAGES, 2018-2030 (USD MILLION)
TABLE 210. FRANCE NUTRACEUTICALS MARKET SIZE, BY FUNCTIONAL FOODS, 2018-2030 (USD MILLION)
TABLE 211. FRANCE NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 212. FRANCE NUTRACEUTICALS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 213. FRANCE NUTRACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 214. FRANCE NUTRACEUTICALS MARKET SIZE, BY DIGESTIVE HEALTH, 2018-2030 (USD MILLION)
TABLE 215. FRANCE NUTRACEUTICALS MARKET SIZE, BY MENTAL HEALTH, 2018-2030 (USD MILLION)
TABLE 216. FRANCE NUTRACEUTICALS MARKET SIZE, BY SPORTS NUTRITION, 2018-2030 (USD MILLION)
TABLE 217. FRANCE NUTRACEUTICALS MARKET SIZE, BY WEIGHT MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 218. FRANCE NUTRACEUTICALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 219. FRANCE NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 220. FRANCE NUTRACEUTICALS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 221. FRANCE NUTRACEUTICALS MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 222. RUSSIA NUTRACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 223. RUSSIA NUTRACEUTICALS MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2030 (USD MILLION)
TABLE 224. RUSSIA NUTRACEUTICALS MARKET SIZE, BY FUNCTIONAL BEVERAGES, 2018-2030 (USD MILLION)
TABLE 225. RUSSIA NUTRACEUTICALS MARKET SIZE, BY FUNCTIONAL FOODS, 2018-2030 (USD MILLION)
TABLE 226. RUSSIA NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 227. RUSSIA NUTRACEUTICALS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 228. RUSSIA NUTRACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 229. RUSSIA NUTRACEUTICALS MARKET SIZE, BY DIGESTIVE HEALTH, 2018-2030 (USD MILLION)
TABLE 230. RUSSIA NUTRACEUTICALS MARKET SIZE, BY MENTAL HEALTH, 2018-2030 (USD MILLION)
TABLE 231. RUSSIA NUTRACEUTICALS MARKET SIZE, BY SPORTS NUTRITION, 2018-2030 (USD MILLION)
TABLE 232. RUSSIA NUTRACEUTICALS MARKET SIZE, BY WEIGHT MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 233. RUSSIA NUTRACEUTICALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 234. RUSSIA NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 235. RUSSIA NUTRACEUTICALS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 236. RUSSIA NUTRACEUTICALS MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 237. ITALY NUTRACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 238. ITALY NUTRACEUTICALS MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2030 (USD MILLION)
TABLE 239. ITALY NUTRACEUTICALS MARKET SIZE, BY FUNCTIONAL BEVERAGES, 2018-2030 (USD MILLION)
TABLE 240. ITALY NUTRACEUTICALS MARKET SIZE, BY FUNCTIONAL FOODS, 2018-2030 (USD MILLION)
TABLE 241. ITALY NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 242. ITALY NUTRACEUTICALS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 243. ITALY NUTRACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 244. ITALY NUTRACEUTICALS MARKET SIZE, BY DIGESTIVE HEALTH, 2018-2030 (USD MILLION)
TABLE 245. ITALY NUTRACEUTICALS MARKET SIZE, BY MENTAL HEALTH, 2018-2030 (USD MILLION)
TABLE 246. ITALY NUTRACEUTICALS MARKET SIZE, BY SPORTS NUTRITION, 2018-2030 (USD MILLION)
TABLE 247. ITALY NUTRACEUTICALS MARKET SIZE, BY WEIGHT MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 248. ITALY NUTRACEUTICALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 249. ITALY NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 250. ITALY NUTRACEUTICALS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 251. ITALY NUTRACEUTICALS MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 252. SPAIN NUTRACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 253. SPAIN NUTRACEUTICALS MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2030 (USD MILLION)
TABLE 254. SPAIN NUTRACEUTICALS MARKET SIZE, BY FUNCTIONAL BEVERAGES, 2018-2030 (USD MILLION)
TABLE 255. SPAIN NUTRACEUTICALS MARKET SIZE, BY FUNCTIONAL FOODS, 2018-2030 (USD MILLION)
TABLE 256. SPAIN NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 257. SPAIN NUTRACEUTICALS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 258. SPAIN NUTRACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 259. SPAIN NUTRACEUTICALS MARKET SIZE, BY DIGESTIVE HEALTH, 2018-2030 (USD MILLION)
TABLE 260. SPAIN NUTRACEUTICALS MARKET SIZE, BY MENTAL HEALTH, 2018-2030 (USD MILLION)
TABLE 261. SPAIN NUTRACEUTICALS MARKET SIZE, BY SPORTS NUTRITION, 2018-2030 (USD MILLION)
TABLE 262. SPAIN NUTRACEUTICALS MARKET SIZE, BY WEIGHT MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 263. SPAIN NUTRACEUTICALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 264. SPAIN NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 265. SPAIN NUTRACEUTICALS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 266. SPAIN NUTRACEUTICALS MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 267. UNITED ARAB EMIRATES NUTRACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 268. UNITED ARAB EMIRATES NUTRACEUTICALS MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2030 (USD MILLION)
TABLE 269. UNITED ARAB EMIRATES NUTRACEUTICALS MARKET SIZE, BY FUNCTIONAL BEVERAGES, 2018-2030 (USD MILLION)
TABLE 270. UNITED ARAB EMIRATES NUTRACEUTICALS MARKET SIZE, BY FUNCTIONAL FOODS, 2018-2030 (USD MILLION)
TABLE 271. UNITED ARAB EMIRATES NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 272. UNITED ARAB EMIRATES NUTRACEUTICALS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 273. UNITED ARAB EMIRATES NUTRACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 274. UNITED ARAB EMIRATES NUTRACEUTICALS MARKET SIZE, BY DIGESTIVE HEALTH, 2018-2030 (USD MILLION)
TABLE 275. UNITED ARAB EMIRATES NUTRACEUTICALS MARKET SIZE, BY MENTAL HEALTH, 2018-2030 (USD MILLION)
TABLE 276. UNITED ARAB EMIRATES NUTRACEUTICALS MARKET SIZE, BY SPORTS NUTRITION, 2018-2030 (USD MILLION)
TABLE 277. UNITED ARAB EMIRATES NUTRACEUTICALS MARKET SIZE, BY WEIGHT MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 278. UNITED ARAB EMIRATES NUTRACEUTICALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 279. UNITED ARAB EMIRATES NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 280. UNITED ARAB EMIRATES NUTRACEUTICALS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 281. UNITED ARAB EMIRATES NUTRACEUTICALS MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 282. SAUDI ARABIA NUTRACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 283. SAUDI ARABIA NUTRACEUTICALS MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2030 (USD MILLION)
TABLE 284. SAUDI ARABIA NUTRACEUTICALS MARKET SIZE, BY FUNCTIONAL BEVERAGES, 2018-2030 (USD MILLION)
TABLE 285. SAUDI ARABIA NUTRACEUTICALS MARKET SIZE, BY FUNCTIONAL FOODS, 2018-2030 (USD MILLION)
TABLE 286. SAUDI ARABIA NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 287. SAUDI ARABIA NUTRACEUTICALS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 288. SAUDI ARABIA NUTRACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 289. SAUDI ARABIA NUTRACEUTICALS MARKET SIZE, BY DIGESTIVE HEALTH, 2018-2030 (USD MILLION)
TABLE 290. SAUDI ARABIA NUTRACEUTICALS MARKET SIZE, BY MENTAL HEALTH, 2018-2030 (USD MILLION)
TABLE 291. SAUDI ARABIA NUTRACEUTICALS MARKET SIZE, BY SPORTS NUTRITION, 2018-2030 (USD MILLION)
TABLE 292. SAUDI ARABIA NUTRACEUTICALS MARKET SIZE, BY WEIGHT MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 293. SAUDI ARABIA NUTRACEUTICALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 294. SAUDI ARABIA NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 295. SAUDI ARABIA NUTRACEUTICALS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 296. SAUDI ARABIA NUTRACEUTICALS MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 297. SOUTH AFRICA NUTRACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 298. SOUTH AFRICA NUTRACEUTICALS MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2030 (USD MILLION)
TABLE 299. SOUTH AFRICA NUTRACEUTICALS MARKET SIZE, BY FUNCTIONAL BEVERAGES, 2018-2030 (USD MILLION)
TABLE 300. SOUTH AFRICA NUTRACEUTICALS MARKET SIZE, BY FUNCTIONAL FOODS, 2018-2030 (USD MILLION)
TABLE 301. SOUTH AFRICA NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 302. SOUTH AFRICA NUTRACEUTICALS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 303. SOUTH AFRICA NUTRACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 304. SOUTH AFRICA NUTRACEUTICALS MARKET SIZE, BY DIGESTIVE HEALTH, 2018-2030 (USD MILLION)
TABLE 305. SOUTH AFRICA NUTRACEUTICALS MARKET SIZE, BY MENTAL HEALTH, 2018-2030 (USD MILLION)
TABLE 306. SOUTH AFRICA NUTRACEUTICALS MARKET SIZE, BY SPORTS NUTRITION, 2018-2030 (USD MILLION)
TABLE 307. SOUTH AFRICA NUTRACEUTICALS MARKET SIZE, BY WEIGHT MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 308. SOUTH AFRICA NUTRACEUTICALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 309. SOUTH AFRICA NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 310. SOUTH AFRICA NUTRACEUTICALS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 311. SOUTH AFRICA NUTRACEUTICALS MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 312. DENMARK NUTRACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 313. DENMARK NUTRACEUTICALS MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2030 (USD MILLION)
TABLE 314. DENMARK NUTRACEUTICALS MARKET SIZE, BY FUNCTIONAL BEVERAGES, 2018-2030 (USD MILLION)
TABLE 315. DENMARK NUTRACEUTICALS MARKET SIZE, BY FUNCTIONAL FOODS, 2018-2030 (USD MILLION)
TABLE 316. DENMARK NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 317. DENMARK NUTRACEUTICALS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 318. DENMARK NUTRACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 319. DENMARK NUTRACEUTICALS MARKET SIZE, BY DIGESTIVE HEALTH, 2018-2030 (USD MILLION)
TABLE 320. DENMARK NUTRACEUTICALS MARKET SIZE, BY MENTAL HEALTH, 2018-2030 (USD MILLION)
TABLE 321. DENMARK NUTRACEUTICALS MARKET SIZE, BY SPORTS NUTRITION, 2018-2030 (USD MILLION)
TABLE 322. DENMARK NUTRACEUTICALS MARKET SIZE, BY WEIGHT MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 323. DENMARK NUTRACEUTICALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 324. DENMARK NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 325. DENMARK NUTRACEUTICALS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 326. DENMARK NUTRACEUTICALS MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 327. NETHERLANDS NUTRACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 328. NETHERLANDS NUTRACEUTICALS MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2030 (USD MILLION)
TABLE 329. NETHERLANDS NUTRACEUTICALS MARKET SIZE, BY FUNCTIONAL BEVERAGES, 2018-2030 (USD MILLION)
TABLE 330. NETHERLANDS NUTRACEUTICALS MARKET SIZE, BY FUNCTIONAL FOODS, 2018-2030 (USD MILLION)
TABLE 331. NETHERLANDS NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 332. NETHERLANDS NUTRACEUTICALS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 333. NETHERLANDS NUTRACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 334. NETHERLANDS NUTRACEUTICALS MARKET SIZE, BY DIGESTIVE HEALTH, 2018-2030 (USD MILLION)
TABLE 335. NETHERLANDS NUTRACEUTICALS MARKET SIZE, BY MENTAL HEALTH, 2018-2030 (USD MILLION)
TABLE 336. NETHERLANDS NUTRACEUTICALS MARKET SIZE, BY SPORTS NUTRITION, 2018-2030 (USD MILLION)
TABLE 337. NETHERLANDS NUTRACEUTICALS MARKET SIZE, BY WEIGHT MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 338. NETHERLANDS NUTRACEUTICALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 339. NETHERLANDS NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 340. NETHERLANDS NUTRACEUTICALS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 341. NETHERLANDS NUTRACEUTICALS MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 342. QATAR NUTRACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 343. QATAR NUTRACEUTICALS MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2030 (USD MILLION)
TABLE 344. QATAR NUTRACEUTICALS MARKET SIZE, BY FUNCTIONAL BEVERAGES, 2018-2030 (USD MILLION)
TABLE 345. QATAR NUTRACEUTICALS MARKET SIZE, BY FUNCTIONAL FOODS, 2018-2030 (USD MILLION)
TABLE 346. QATAR NUTRACEUTICALS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
TABLE 347. QATAR NUTRACEUTICALS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 348. QATAR NUTRACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 349. QATAR NUTRACEUTICALS MARKET SIZE, BY DIGESTIVE HEALTH, 2018-2030 (USD MILLION)
TABLE 350. QATAR NUTRACEUTICALS MARKET SIZE, BY MENTAL HEALTH, 2018-2030 (USD MILLION)
TABLE 351. QATAR NUTRACEUTICALS MARKET SIZE, BY SPORTS NUTRITION, 2018-2030 (USD MILLION)
TABLE 352. QATAR NUTRACEUTICALS MARKET SIZE, BY WEIGHT MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 353. QATAR NUTRACEUTICALS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 354. QATAR NUTRACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 355. QATAR NUTRACEUTICALS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 356. QATAR NUTRACEUTICALS MARKET SIZE, BY ONLINE, 2018-2030 (USD MILLION)
TABLE 357. FINLAND NUTRACEUTICALS MARKET SIZE, BY PRODU

Companies Mentioned

The companies profiled in this Nutraceuticals market report include:
  • Ajinomoto Co., Inc.
  • Amway Corporation
  • Archer Daniels Midland Company
  • Associated British Foods PLC
  • Balchem Corporation
  • Barentz International B.V.
  • BASF SE
  • Bayer AG
  • BIONAP S.R.L.
  • Cargill Incorporated
  • Chr. Hansen Holding A/S
  • Divi's Laboratories Limited
  • DSM-Firmenich AG
  • DuPont de Nemours, Inc.
  • Fonterra Co-Operative Group Limited
  • Glanbia PLC
  • Ingredion Incorporated
  • Jamieson Wellness Inc.
  • Kerry Group PLC
  • Kyowa Hakko USA, Inc.
  • Lonza Group Ltd
  • Martin Bauer Group
  • Nestle S.A.
  • Nutricia by Danone S.A.
  • Pfizer Inc.
  • Sydler India Pvt. Ltd.
  • ZIVO Bioscience, Inc.

Methodology

Loading
LOADING...

Table Information